April 07, 2022
LUND, Sweden, April 7, 2022 /PRNewswire/ -- Hansa Biopharma AB "Hansa" (Nasdaq Stockholm: HNSA), a pioneer in enzyme technology for rare immunological conditions, today announced the release of the Annual Report 2021 Søren Tulstrup, President and CEO of Hansa Biopharma, comments: 2021...
Source URL: https://www.prnewswire.com:443/news-releases/hansa-biopharma-publishes-annual-report-2021-301519710.html
|
